These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 7860579)

  • 21. [Tuberculosis and live with special reference to lesions due to antimycobacterial agents].
    Daddi G; Boccitto G; Storniello G; Salvati F
    Epatologia; 1970; 16(1):71-6. PubMed ID: 5525569
    [No Abstract]   [Full Text] [Related]  

  • 22. Treatment of childhood tuberculosis: consensus statement of IAP Working Group.
    Amdekar YK
    Indian Pediatr; 1998 Dec; 35(12):1263-4. PubMed ID: 10216716
    [No Abstract]   [Full Text] [Related]  

  • 23. How much isoniazid is needed for prevention of tuberculosis among immunocompetent adults?
    Moulding T
    Int J Tuberc Lung Dis; 2000 May; 4(5):485-6. PubMed ID: 10815744
    [No Abstract]   [Full Text] [Related]  

  • 24. [Radioisotope study of liver function in drug-induced toxico-allergic reactions in patients with ruberculosis].
    Vil'derman AM; Frenkel' VKh; Reznik SE; Tikhun MN
    Med Radiol (Mosk); 1967 Apr; 12(4):62-6. PubMed ID: 6052187
    [No Abstract]   [Full Text] [Related]  

  • 25. [Side-effects of antituberculous drugs observed in five different regimens (author's transl)].
    Aizawa H; Sakai K; Kishida K
    Kekkaku; 1977 May; 52(5):229-34. PubMed ID: 886680
    [No Abstract]   [Full Text] [Related]  

  • 26. Liver function tests during treatment of tuberculosis with short-course regimens containing isoniazid, rifampicin & pyrazinamide.
    Swamy R; Acharyulu GS; Duraipandian M; Jawahar MS; Ramachandran R; Sarma GR
    Indian J Med Res; 1987 Nov; 86():549-57. PubMed ID: 3451899
    [No Abstract]   [Full Text] [Related]  

  • 27. Alcoholic hepatic impairment complicating treatment with hepatotoxic antituberculosis drugs.
    Tiwari VK
    J Indian Med Assoc; 1996 Sep; 94(9):347-8. PubMed ID: 9019083
    [No Abstract]   [Full Text] [Related]  

  • 28. [Controversy over tuberculosis therapy in HIV infected patients. Isoniazide therapy--brief chemotherapy].
    Arnheim K
    Fortschr Med; 1995 Dec; 113(35-36):14-5. PubMed ID: 8582689
    [No Abstract]   [Full Text] [Related]  

  • 29. Chemotherapy of tuberculosis for the 1980's.
    Dutt AK; Stead WW
    Clin Chest Med; 1980 May; 1(2):243-52. PubMed ID: 6794977
    [No Abstract]   [Full Text] [Related]  

  • 30. Hepatotoxicity to different antituberculosis drug combinations.
    Aziz S; Agha F; Hassan R; Fairoz SA; Hassan K
    J Pak Med Assoc; 1990 Dec; 40(12):290-4. PubMed ID: 2126569
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [A study of 172 patients with hepatic injury caused by antituberculosis drugs].
    Cheng SQ
    Zhonghua Gan Zang Bing Za Zhi; 2004 Sep; 12(9):571. PubMed ID: 15387923
    [No Abstract]   [Full Text] [Related]  

  • 32. [Use of a mathematic method of prognosis in adverse reactions to chemotherapy of tuberculosis].
    Kazakov KS; Kozarev MI
    Probl Tuberk; 1987; (2):43-5. PubMed ID: 3575279
    [No Abstract]   [Full Text] [Related]  

  • 33. [Liver damage from tuberculosis treatment].
    Keiner F
    Med Klin; 1981 Jun; 76(13):376-7. PubMed ID: 7254121
    [No Abstract]   [Full Text] [Related]  

  • 34. The hunt for the elusive surrogate marker of sterilizing activity in tuberculosis treatment.
    Burman WJ
    Am J Respir Crit Care Med; 2003 May; 167(10):1299-301. PubMed ID: 12738594
    [No Abstract]   [Full Text] [Related]  

  • 35. [Ultrasonic examination of the liver in patients with pulmonary tuberculosis].
    Ivanov AK; Dzodzuashvili KA
    Klin Med (Mosk); 1990 Jan; 68(1):100-3. PubMed ID: 2186199
    [No Abstract]   [Full Text] [Related]  

  • 36. [Value of some liver function tests routinely performed in early detection of damage to liver parenchyma in patients with pulmonary tuberculosis].
    Pruszyńska S
    Gruzlica; 1971 Dec; 39(12):1205-9. PubMed ID: 5139239
    [No Abstract]   [Full Text] [Related]  

  • 37. [Guidelines for chemotherapy of tuberculosis. German Central Committee for Control of Tuberculosis].
    Pneumologie; 1994 May; 48 Suppl 1():367-72. PubMed ID: 8084885
    [No Abstract]   [Full Text] [Related]  

  • 38. [Use of Astragalus dasyanthus in lesions of the liver in patients with pulmonary tuberculosis].
    Skakun NP; Blikhar EI; Oleĭnik AN
    Vrach Delo; 1988 Jun; (6):51-4. PubMed ID: 3420913
    [No Abstract]   [Full Text] [Related]  

  • 39. [The clinico-immunological variants of drug-induced toxic hepatitis in pulmonary tuberculosis patients].
    Frolov VM; Peresadin NA; Petrunia AM
    Probl Tuberk; 1993; (6):17-9. PubMed ID: 8290522
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Alternative anti-tuberculosis regimen including ofloxacin for the treatment of patients with hepatic injury.
    Szklo A; Mello FC; Guerra RL; Dorman SE; Muzy-de-Souza GR; Conde MB
    Int J Tuberc Lung Dis; 2007 Jul; 11(7):775-80. PubMed ID: 17609053
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.